The goal of this clinical research study is to learn how well magnetic resonance thermal
imaging (MRTI) can check the amount of tumor being destroyed using a therapy called laser
ablation (a procedure that uses lasers to create heat that is designed to destroy cancer
Laser ablation is designed to destroy tumor tissue with the use of fiber optics that are
placed directly into the tumor to deliver laser light energy into the tissue.
In this study, tumor destruction will be checked using MRTI. MRTI is very similar to other
MRI techniques, but instead of providing imaging data, MRTI will provide temperature data for
cancerous areas in the body during the laser ablation process. If tumor temperature can be
measured more accurately, the laser ablation process may be safer.
Laser Ablation and the MRTI Scan:
If you are found to be eligible to take part in this study, on the day you have laser
ablation, you will have an intravenous (IV) line placed. You will receive sedation or general
anaesthesia (drugs to make you sleep) through a needle in your vein over 1-3 hours to lessen
any pain you may have during the procedure. This process will be explained to you.
After receiving the anaesthesia, the following tests and procedures will be performed:
- You will have a limited MRI.
- Your skin will be cleaned and covered with sterile towels and sheets to lower the chance
of an infection.
- The doctor will use MRI scans to place a special needle (applicator) into the tumor.
This applicator will be used to create heat at a high enough temperature that cells can
be destroyed. Small masses may be destroyed in 1 treatment, but larger masses may
require that the needle is placed several times. Each heating cycle takes less than 10
- During laser ablation, MRTI will be used to monitor the temperature within the ablation
zone. The MRTI process is very similar to regular MRI.
- Your heart rate and blood pressure will be measured during the entire procedure.
- The entire procedure may take about 1-3 hours, depending on the size and location of
After the procedure is completed, you will be kept in the hospital for 4-6 hours for
observation. You will be checked for recovery from the sedation that you received during the
procedure. Once you have recovered from the procedure, you will be allowed to leave the
hospital. If you have side effects from the procedure, the doctor may decide to keep you in
the hospital for a longer time period for observation.
After you have completed the procedure, you will return to M. D. Anderson for follow-up
visits. About one (1) week after the laser ablation, you will have a physical exam and an
X-ray. About one (1) month after the laser ablation, you will have a physical exam and a
limited MRI to check the status of the disease.
Length of Study:
You will be considered off-study after the 1-month follow up visit.
This is an investigational study. The laser ablation procedure is an FDA-approved procedure.
The devices are commercially available and can be used outside research studies. The
investigational part of this study involves using MRTI to check the effect of ablation on the
tumor. Up to 24 participants will be enrolled in this study. All will be enrolled at M.D.
1. Patients with tumor metastases to the skeleton who are referred to interventional
radiology for percutaneous ablation
2. Surgery is not a viable or desirable alternative therapy at the time of enrollment
3. Radiation therapy has failed or not indicated or can be safely postponed
4. Symptomatic or asymptomatic tumor size less than or equal to 3 cm in its largest
5. Performance status is Eastern Cooperative Oncology Group 2 or better in adults
6. Patient is able to undergo MRI
7. Patients at least 18 years of age
1. Patients with uncorrectable coagulopathy
2. Patients with pacemaker or defibrillator
3. Patients with metallic prosthesis at the site of the intended ablation
4. Patients with spinal cord compression or epidural tumor extension
5. Patients with vertebral body metastases exhibiting posterior wall destruction
6. Patients with any soft tissue extension of a vertebral tumor
7. Patients with any metastasis that is extrinsically located in vertebra or any long
bones of the extremities compromising the cortex
8. Patients with tumors having direct extension or involvement of a joint capsule or a
9. Patients with Neutropenia (ANC less then 1000) or known active infection
10. Patients unable to undergo conscious sedation
11. Children under 18 years of age will be excluded from this study